2017 Mo-99 Topical Meeting

Sept. 10-13, 2017 — Montreal Marriott Chateau Champlain, Montreal, QC Canada


  • NNSA’s 2017 Mo-99 Topical Meeting
    Organized by Argonne National Laboratory, the meeting will take place in Montreal, QC Canada from Sept. 10-13, 2017.
    Details…

  • Hotel
    The meeting will be at the Montreal Marriott Chateau Champlain located in Montreal, QC Canada.
    Details…

  • Venue
    of the meeting will be Montreal, Canada's second largest city. With 3.4 million inhabitants, it’s a major inland port, an international metropolis and the world’s second-largest French-speaking city. 
    Details…

  • Instructions for Authors
    Iinstructions for authors, including documents and deadlines.
    Instructions for Authors…

  • Register
    For more information visit:
    Online registration…

  • Visa
    Entry and exit requirements for Canada.
    Details…

  • Organizers
    Find contact information
    Contact...

Program and Workshop Overview

The U.S. Department of Energy’s (DOE) National Nuclear Security Administration (NNSA) manages the Material Management and Minimization (M3) Conversion Program that was established in 2015, being a continuation of the Global Threat Reduction Initiative (GTRI) and Reduced Enrichment for Research and Test Reactors (RERTR) Programs that were established in 2004 and 1978 respectively. The M3 Conversion Program mission supports minimization and, to the extent possible, elimination of the use of highly-enriched uranium (HEU) in civil nuclear applications by working to convert research reactors and isotope production processes to the use of low-enriched uranium (LEU) fuel and targets throughout the world. Over the past few years, unexpected shutdowns at the major molybdenum-99 (Mo-99) production facilities have resulted in significant shortages of this important medical isotope. Because of this, the United States is currently situated at the nexus of two related priorities: discouraging the use of proliferation-sensitive HEU in civilian applications and overcoming a health crisis from the lack of a sufficient, reliable supply of Mo-99.

M3 provides support to establish reliable supplies of Mo-99, produced without HEU, for the United States by providing assistance to convert current production from HEU targets to LEU targets and to accelerate existing commercial projects in the United States to produce Mo-99 without the use of HEU by the end of 2016. Through these actions M3's Mo-99 program is addressing both issues of nonproliferation and reliability of supply.

Current and Past Mo-99 Topical Meetings

2017 Mo-99 Topical Meeting (Montreal) 2016 Mo-99 Topical Meeting (St. Louis) 2015 Mo-99 Topical Meeting (Boston) 2014 Mo-99 Topical Meeting (Washington D.C.)

Questions?

For further information and questions please contact the Organizing Committee.

2017 Mo-99 Topical Meeting

Mo-99 2017 News:

May 05, 2017Mo-99 2017 Announced: Mo-99 2017 will be held in Montreal, QC Canada, September 10-13, 2017.

For more information:

Technical Questions:
For further information and questions please contact:

John Holland
Argonne National Laboratory

Administrative Questions:
Mrs. Karen Grudzinski
Argonne National Laboratory
9700 South Cass Avenue, Building 208
Argonne, Illinois 60439-4815, U.S.A.
Phone: +1 (630) 252-1671
Fax: +1 (630) 252-5161

HOST

NNSA logo

ORGANIZER

Argonne logo

HOST: NNSA logo ORGANIZER: Argonne logo